Rejected from Nature Neuroscience? Where to Submit Next

In Manusights pre-submission and post-rejection review work on Nature Neuroscience-targeted manuscripts, the recurring issue is not simply selectivity. The issue is whether a paper explains a nervous-system principle with enough causal evidence and enough audience breadth. Nature Neuroscience can publish work from any neuroscience area, but the manuscript normally has to travel beyond one local assay, one brain region, one disease model, or one computational result.

Evidence basis: Of the 50+ manuscripts we reviewed or pre-screened in this neuroscience lane, the specific rejection pattern we see most often is an editorial triage pattern where the paper is technically strong but still reads as descriptive. Manusights review data also shows a second recurring pattern: authors treat a transfer route as a replacement for repair, even when the reviewer criticism was about causal evidence, controls, or audience breadth. SciRev community reports are only a supporting author-experience signal here, not the basis for an author-specific prediction.

Nature Neuroscience pattern 1: neural activity is described, not causally tested. Imaging, electrophysiology, transcriptomics, connectomics, or behavior data may be rich, but the manuscript does not show whether the signal is necessary, sufficient, or mechanistically explanatory. If the figures stop at correlation, the next journal should either value descriptive depth or receive a repaired causal package.

Nature Neuroscience pattern 2: the paper is too local for a broad neuroscience audience. A result may matter inside one model system, disease subtype, behavioral task, or computational framework, but the abstract and first figure do not show why it changes how neuroscientists outside that niche think. Neuron, Nature Communications, eLife, or Journal of Neuroscience will each apply this breadth question differently.

Nature Neuroscience pattern 3: controls are not strong enough for the claim. Viral constructs, cell-type specificity, behavioral confounds, sex balance, sample size, imaging preprocessing, electrophysiology QC, lesion or stimulation specificity, randomization, blinding, and code availability often decide whether reviewers trust the mechanism.

Nature Neuroscience pattern 4: disease relevance outruns the model. A mouse, organoid, imaging, or patient-cohort result can be important without proving a therapeutic claim. If the rejected version implies clinical translation before the evidence supports it, the next submission should narrow or repair the disease language.

Nature Neuroscience pattern 5: the transfer suggestion is treated as a decision. A Nature Portfolio transfer can save time, but it does not solve a weak causal claim or narrow audience fit. The receiving journal still needs a manuscript shaped for its readers.

Nature Neuroscience pattern 6: the methods file carries too much of the trust burden. If the main text depends on supplementary methods, unavailable code, vague exclusions, or incomplete statistics to make the result believable, the next submission may repeat the same reviewer resistance.

Check which Nature Neuroscience rejection pattern your paper fits →

Start by separating fit from evidence. A fit rejection means the paper may be sound but not broad enough for Nature Neuroscience. An evidence rejection means the next journal will likely find the same problem unless you repair the manuscript. A significance rejection means the current claim may be too narrow or too descriptive for the journal's multidisciplinary readership.

The strongest retargeting question is: what nervous-system principle does this paper explain? If the answer is causal, mechanistic, and relevant across a field, Neuron, Nature Communications, eLife, or Journal of Neuroscience may remain plausible. If the answer is a rigorous but narrower result inside one circuit, disease model, imaging dataset, or computational method, a specialist route may be cleaner. If the paper's real strength is disease mechanism, Biological Psychiatry or another translational venue may fit better than another broad-neuroscience journal.

Do not submit unchanged because the Nature Neuroscience decision was fast. A 9-day median first decision means triage is normal, not superficial. If an editor rejected the manuscript before review, the next version should make the causal mechanism, audience breadth, and field-level consequence visible in the title, abstract, first two figures, and cover letter.

If rejection came after review, keep the useful parts of the reviewer work. A strong post-review transfer or resubmission plan should preserve the experiments reviewers valued, repair the controls they criticized, and explicitly narrow claims that were unsupported. If the paper needs new experiments, do them before choosing the next journal.

Use transfer only when the destination journal matches the repaired manuscript. Nature Communications may fit a broad and validated result. Communications Biology may fit a technically sound narrower result. A society or specialist journal may be better when the paper's real value is within a specific subfield.

First, classify every editor or reviewer comment as scope, causal mechanism, breadth, controls, methods, statistics, behavior, imaging, electrophysiology, disease relevance, data availability, novelty, or writing. A scope problem needs a route decision. A causal or methods problem needs a manuscript repair.

Second, reread the title, abstract, first two figures, key perturbation experiment, behavioral or physiological result, statistics paragraph, limitations, and cover letter together. If the broad neuroscience claim is visible only after specialist translation, the next editor may miss it too. The first page should show why the paper matters beyond one local system.

Third, write a one-paragraph retargeting memo:

Fourth, revise for the next journal's readers. A Neuron submission should foreground conceptual advance and mechanistic depth. A Nature Communications submission should foreground broad relevance and validation. A Journal of Neuroscience submission should foreground field-level rigor. A Cerebral Cortex or Biological Psychiatry submission should foreground the correct subfield audience.

Run a Nature Neuroscience rejection and retargeting check →

This page is a post-rejection routing guide, not an official Nature Neuroscience policy page. Nature Portfolio pages control the journal instructions, peer-review policy, metrics, and publishing options. Manusights adds the author-side decision layer: whether the rejected manuscript should be repaired for a causal neuroscience claim, routed to a broader Nature Portfolio journal, shifted to Neuron or another selective neuroscience title, reframed for a society journal, or narrowed for a technically sound specialist venue.